Masahiro Nishimoto

625 total citations
27 papers, 519 citations indexed

About

Masahiro Nishimoto is a scholar working on Organic Chemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masahiro Nishimoto has authored 27 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masahiro Nishimoto's work include Synthesis of heterocyclic compounds (4 papers), Diabetes Treatment and Management (4 papers) and Chemical Reaction Mechanisms (4 papers). Masahiro Nishimoto is often cited by papers focused on Synthesis of heterocyclic compounds (4 papers), Diabetes Treatment and Management (4 papers) and Chemical Reaction Mechanisms (4 papers). Masahiro Nishimoto collaborates with scholars based in Japan, United States and Canada. Masahiro Nishimoto's co-authors include Yoshihito Ohtake, Kazumi Morikawa, Motomitsu Kitaoka, Tsutomu Sato, Koji Takano, Takeshi Imanishi, Kazuyuki Miyashita, Satoshi Obika, Masayuki Suzuki and Masayuki Ohmori and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Electrochimica Acta.

In The Last Decade

Masahiro Nishimoto

25 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Nishimoto Japan 14 211 196 112 62 57 27 519
Hsiu‐Chien Chan Taiwan 13 75 0.4× 339 1.7× 71 0.6× 23 0.4× 102 1.8× 24 531
Roghayeh Pourbagher Iran 12 123 0.6× 177 0.9× 55 0.5× 25 0.4× 20 0.4× 27 526
Matthew L. Brown United States 12 117 0.6× 463 2.4× 48 0.4× 76 1.2× 9 0.2× 16 770
Lutz Haalck Germany 14 73 0.3× 494 2.5× 25 0.2× 39 0.6× 151 2.6× 24 662
Frank W. Perrella United States 9 111 0.5× 353 1.8× 21 0.2× 22 0.4× 35 0.6× 15 589
Yohji Ezure Japan 14 261 1.2× 285 1.5× 15 0.1× 46 0.7× 72 1.3× 31 478
Saibal Kumar Das India 14 446 2.1× 368 1.9× 47 0.4× 23 0.4× 16 0.3× 45 675
C.J. Gray United Kingdom 16 123 0.6× 409 2.1× 23 0.2× 57 0.9× 112 2.0× 56 645
Yadong Lu China 13 68 0.3× 155 0.8× 43 0.4× 35 0.6× 6 0.1× 16 449
Robert T. Lyons United States 10 72 0.3× 235 1.2× 46 0.4× 32 0.5× 5 0.1× 11 598

Countries citing papers authored by Masahiro Nishimoto

Since Specialization
Citations

This map shows the geographic impact of Masahiro Nishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Nishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Nishimoto more than expected).

Fields of papers citing papers by Masahiro Nishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Nishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Nishimoto. The network helps show where Masahiro Nishimoto may publish in the future.

Co-authorship network of co-authors of Masahiro Nishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Nishimoto. A scholar is included among the top collaborators of Masahiro Nishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Nishimoto. Masahiro Nishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohtake, Yoshihito, Takashi Emura, Masahiro Nishimoto, et al.. (2016). Development of a Scalable Synthesis of Tofogliflozin. The Journal of Organic Chemistry. 81(5). 2148–2153. 19 indexed citations
2.
3.
Koyama, Yoshiyuki, et al.. (2013). Directed evolution to enhance thermostability of galacto-N-biose/lacto-N-biose I phosphorylase. Protein Engineering Design and Selection. 26(11). 755–761. 14 indexed citations
4.
Viborg, Alexander Holm, Takane Katayama, Maher Abou Hachem, et al.. (2013). Distinct substrate specificities of three glycoside hydrolase family 42  -galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697. Glycobiology. 24(2). 208–216. 39 indexed citations
5.
Ohtake, Yoshihito, Tsutomu Sato, Hiroharu Matsuoka, et al.. (2012). C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry. 20(13). 4117–4127. 13 indexed citations
6.
Ohtake, Yoshihito, Tsutomu Sato, Hiroharu Matsuoka, et al.. (2011). 5a-Carba-β-d-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry. 19(18). 5334–5341. 19 indexed citations
7.
Nishimoto, Masahiro, Yoshihito Ohtake, Toshiaki Tsunenari, et al.. (2006). Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens. Bioorganic & Medicinal Chemistry Letters. 16(15). 4090–4094. 28 indexed citations
8.
Nishimoto, Masahiro, Yoshihito Ohtake, Iwao Ohizumi, et al.. (2006). Newly discovered orally active pure antiestrogens. Bioorganic & Medicinal Chemistry Letters. 16(18). 4959–4964. 12 indexed citations
9.
Kim, Myung‐Hwa, Masahiro Nishimoto, Yoshihito Ohtake, et al.. (2006). Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure–activity relationship. Bioorganic & Medicinal Chemistry. 14(14). 4803–4819. 19 indexed citations
10.
Cheng, Jie‐Fei, Yujin Huang, Masahiro Nishimoto, et al.. (2006). Discovery of Potent and Orally Available Malonyl-CoA Decarboxylase Inhibitors as Cardioprotective Agents. Journal of Medicinal Chemistry. 49(14). 4055–4058. 40 indexed citations
11.
Cheng, Jie‐Fei, Chi Ching Mak, Yujin Huang, et al.. (2006). Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3484–3488. 14 indexed citations
12.
Imanishi, Takeshi, et al.. (1997). Syntheses of 1-Substituted (SS)-3-p-Tolylsulfinyl-1,4-dihydropyridines, Chiral NADH Model Compounds. Heterocycles. 44(1). 537–537. 8 indexed citations
13.
14.
15.
Miyashita, Kazuyuki, Masahiro Nishimoto, Satoshi Obika, et al.. (1996). Effect of the neighbouring oxygenated substituent on asymmetric reduction with Hantzsch-type 1,4-dihydropyridines having a chiral sulfinyl group. Chemical Communications. 2535–2535. 5 indexed citations
16.
Miyashita, Kazuyuki, Masahiro Nishimoto, Tetsuya Ishino, Satoshi Obika, & Takeshi Imanishi. (1995). Novel and chiral hantzsch-type 1,4-dihydropyridines having A p-tolylsulfinyl group. Synthesis and biological activities as calcium channel antagonists.. Chemical and Pharmaceutical Bulletin. 43(4). 711–713. 9 indexed citations
17.
Nishimoto, Masahiro, et al.. (1961). THE SHEAR MODULUS OF RUBBER AND ITS MEASUREMENT. NIPPON GOMU KYOKAISHI. 34(5). 346–353. 1 indexed citations
18.
Amano, Tetsuki, et al.. (1955). Studies on the Immune Bacteriolysis. VI. Cause of the Death of Bacteria by Immune Bacteriolysis.. 6(1). 57–66. 3 indexed citations
19.
Amano, T, Shinya Inai, Shuzo Kashiba, et al.. (1954). Studies on the Immune Bacteriolysis. I. Accelerating Effect on the Immune Bacteriolysis by Lysozyme-Like Substance of Leucocytes and Egg-White Lysozyme.. 4(4). 18 indexed citations
20.
Amano, Tetsuki, Shinya Inai, Shuzo Kashiba, et al.. (1954). Studies on the Immune Bacteriolysis. II. The Effect of Platelet Extract on the Immune Bacteriolysis.. 4(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsiu‐Chien Chan Breakdown of academic impact, for papers by Roghayeh Pourbagher Breakdown of academic impact, for papers by Matthew L. Brown Breakdown of academic impact, for papers by Lutz Haalck Breakdown of academic impact, for papers by Frank W. Perrella Breakdown of academic impact, for papers by Yohji Ezure Breakdown of academic impact, for papers by Saibal Kumar Das Breakdown of academic impact, for papers by C.J. Gray Breakdown of academic impact, for papers by Yadong Lu Breakdown of academic impact, for papers by Robert T. Lyons
Rankless by CCL
2026